Smooth Slow Scroll with Pause
Top 100 most promising companies in USA by Silicon.
Leverage KOL Sentiment Analysis for Strategic Action.
Single platform for Medical and Marketing teams with strict compliance firewalls.

Transform HCP Insights into Impact - A Masterclass with Industry Leaders

If you can't measure it, how can you improve? The importance of impact-driven engagement

Fill the form below to watch the full webinar

Webinar Speakers

Andrea Martins Bayer

Andrea Martins Bayer

American Thoracic Society
Ex. Novartis, GSK

Madoc Walmsley

Madoc Walmsley

Sr. Director, Head of TLL, Alexion Pharmaceuticals Inc
Alexion Pharmaceuticals

Badal Shah

Founder and President Neolytica
(Moderator)

About Webinar

Transform HCP insights into Impact- A Masterclass with Industry leaders is a webinar series crafted to bring together prominent thought leaders and experts to explore the transformative topics that are shaping the Key External Expert (KEE) engagement insights generating impact measurement and precision communication between pharma and HCPs. Our goal is to provide valuable insights, foster discussion, and drive innovation within the sector.

This session will delve into the dynamic landscape of KEE strategic engagement, exploring the latest trends, challenges, and opportunities. We anticipate a rich discussion covering a range of topics, including:

The Role of Measurement in Medical Affairs: In the field of medical affairs, measurement is vital for assessing the effectiveness of engagement with healthcare professionals, patients, and other stakeholders. Without tracking key metrics such as feedback, outcomes, and engagement levels, it becomes impossible to identify areas for improvement. By implementing robust measurement strategies, medical affairs teams can enhance their interactions, ensuring they provide relevant information and drive impactful change in patient care.

Maximizing Impact-Driven Engagement: Impact-driven engagement in medical affairs goes beyond traditional communication. It focuses on fostering meaningful relationships with healthcare providers, ensuring that the engagement is not only informative but also transformative in improving patient outcomes. By measuring the success of these interactions, medical affairs teams can continuously refine their strategies, ensuring that their efforts align with healthcare objectives and lead to measurable, positive impacts on both providers and patients.

For future Webinar & Event updates subscribe to our newsletter.

Scroll to Top

Andrea Martins Bayer

Andrea brings over 20 years of experience in Medical Affairs, Marketing, and Market Access, working with healthcare organizations across the U.S., Latin America, and Europe.

She has led cross-functional teams and developed strategies that drive results in complex, multicultural environments. Andrea has expertise in leveraging data and AI tools to support strategic decision-making, enhance engagement, and implement long-term plans.

Madoc Walmsley

With over 24 years of experience in the pharmaceutical and biotech industry, Madoc Walmsley has built a diverse and impactful career spanning sales, marketing, and leadership roles. For the past 5 years, Madoc has led a high-performing Thought Leader Liaison team, driving strategic engagement with key opinion leaders to advance medical education and advocacy.

His background includes early experience in the capital equipment and medical device sectors, followed by the last 14 years dedicated to rare diseases—a space where he has found his greatest purpose. Madoc is deeply passionate about improving patient lives, building strong partnerships with the KOL community, and working to shorten the often lengthy and challenging diagnostic journey for those with rare conditions. His commitment to patients and relentless focus on collaboration continue to fuel his mission to bring meaningful change to the rare disease landscape.

Badal Shah

Badal Shah has transformed the approach to affecting successful outcomes inside the arena of thought leadership within health and life sciences. It was his vision to start a subsidiary company completely focused on Data analytics and Artificial intelligence. He will be the Managing Director of Neolytica and responsible for its growth and P&L.

  • Recognized as “Top 100 Healthcare leaders” by International Forum on Advancement in Healthcare (IFAH) and was also nominated for “Forbes 30 under 30” in Healthcare in 2018.
  • Pioneered the innovative approach of “How to achieve effective medical communication and optimize field force during pre and post drug launches” supporting numerous successful drug launches.
  • He was also part of the team to establish KOL mapping business at Veeva systems, before joining QPharma.